In 2023, prior to the forecasted data, cardiovascular system medicine sales in Italy were valued at approximately $96.4 US Dollars PPP per capita. In 2024, the forecast shows an increase to $98.2, marking a 1.87% year-on-year growth. By 2025, sales are expected to grow by 1.93%, and in 2026, the sector is projected to see a 1.40% increase. A further rise of 1.18% is anticipated in 2027, with 2028 experiencing a 0.88% growth. The compound annual growth rate (CAGR) from 2024 to 2028 is estimated at 1.36%.
Future trends to watch for include developments in personalized medicine, increasing prevalence of cardiovascular diseases due to aging populations, and technological advancements in treatment methods. Healthcare policies and economic conditions in Italy will also significantly impact market dynamics in the coming years.
